Patients did not consent to have their data publicly available, therefore, data are from the MONICA/KORA S3/F3 study whose authors may be contacted at the Institute of Epidemiology II of Helmholtz Zentrum München, Germany. The authors confirm that data will be made available on request. The person who may be contacted is Prof. Annette Peters (<peters@helmholtz-muenchen.de>).

Introduction {#sec005}
============

Hemoglobin A~1c~ (HbA~1c~) reflects the percentage of glycated hemoglobin, which results from non-enzymatic attachment of glucose to hemoglobin. Levels of HbA~1c~ indicate the long-term average blood glucose level over the previous 8--12 weeks \[[@pone.0139244.ref001]\]. Values ≥ 6.5% can be used for the diagnosis of diabetes \[[@pone.0139244.ref002]\]. Besides its use as a diagnostic tool, HbA~1c~ has been investigated as a marker for cardiovascular risk. An increase in HbA~1c~ levels of 1% is associated with a 17% increase in risk of cardiovascular disease and a 15% increase in risk of all-cause mortality in subjects with type 2 diabetes \[[@pone.0139244.ref003]\]. The increased risk of cardiovascular complications with higher HbA~1c~ levels is not only evident in those with established diabetes, but also in non-diabetic adults \[[@pone.0139244.ref004]--[@pone.0139244.ref007]\]. In the latter, HbA~1c~ levels are more strongly associated with coronary heart disease risk than other glycemic measures \[[@pone.0139244.ref008]\], and all-cause mortality risk increases by 26% with a 1% increase in HbA~1c~ concentration \[[@pone.0139244.ref009]\]. Therefore, HbA~1c~ should be investigated continuously in the assessment of cardiovascular and mortality risk \[[@pone.0139244.ref009]\].

Previous studies on the association between vitamins/minerals and HbA~1c~ levels investigated the effect of vitamin E, vitamin C, vitamin D, vitamin B~1~, folic acid, carotenoids (β-carotene), calcium, magnesium, zinc, iron, and selenium \[[@pone.0139244.ref010]--[@pone.0139244.ref033]\]. For most nutrients, the results were not consistent between studies that investigated the same nutrients as exposure. Furthermore, all the above mentioned intervention studies were conducted in diabetic patients or high risk populations \[[@pone.0139244.ref010]--[@pone.0139244.ref027]\]. However, supplementation of nutrients might be less effective if the disease has already developed \[[@pone.0139244.ref011],[@pone.0139244.ref014]\]. Therefore, investigations in non-diabetic populations are warranted. Population-based studies conducted to date have been of cross-sectional design \[[@pone.0139244.ref028],[@pone.0139244.ref029],[@pone.0139244.ref032],[@pone.0139244.ref033]\], which precludes conclusions regarding causal relationships. Considering that chronic diseases develop over a period of several years, it is particularly important to conduct long-term studies to investigate potential prevention strategies.

To our knowledge, there is currently no population-based longitudinal study of the association between the use of different vitamin or mineral supplements and change in HbA~1c~ levels in the general healthy population. As the use of dietary supplements could be a promising and feasible strategy to prevent hyperglycemia related complications, the aim of the study was to investigate the longitudinal relationship between the intake of vitamins/minerals from supplements and medications with HbA~1c~ concentrations over 10 years in a population-based sample of non-diabetic people.

Methods {#sec006}
=======

Study description and population {#sec007}
--------------------------------

Baseline data were available from the population-based Monitoring of Trends and Determinants in Cardiovascular Diseases (MONICA) Augsburg S3 survey conducted in the years 1994/95 as part of the international World Health Organization (WHO) MONICA project \[[@pone.0139244.ref034]\]. The study region comprised the city of Augsburg (Germany) and its two surrounding counties. A total of 6640 participants aged 25--74 years were randomly selected by a two-stage cluster sampling method, of whom 4856 participated (73.1%) \[[@pone.0139244.ref035]\]. Of these, 3006 participants took part in the subsequent Cooperative Health Research in the Region of Augsburg (KORA) F3 survey after 10 years of follow-up \[[@pone.0139244.ref036]\]. After exclusion of diabetic individuals at baseline, either clinically diagnosed (n = 241) or with baseline HbA~1c~ levels ≥ 6.5% (n = 57), those who ingested antidiabetic medication at baseline or follow-up (n = 109), and participants with missing HbA~1c~ values at baseline and follow-up (n = 2), the final study population comprised 4447 subjects at baseline and 2774 at follow-up.

The study was conducted according to the guidelines laid down in the Declaration of Helsinki, and all procedures involving human subjects were approved by the ethics committee of the Bavarian Chamber of Physicians (Munich, Germany). Written informed consent was obtained from all participants.

Data collection {#sec008}
---------------

### Outcome {#sec009}

The outcome HbA~1c~ was assessed at baseline (1994/95) and at follow-up (2004/05). Non-fasting blood samples were collected according to a standardized procedure. HbA~1c~ was measured with turbidimetric immunoassays (Tina-quant® Hämoglobin A~1c~, Boehringer Mannheim, Mannheim, Germany, and Dimension Rxl 5 Dade-Behring (TINA) with coefficients of variation (CVs) \< 5%) at baseline and follow-up. HbA~1c~ was treated as a continuous variable in all analyses.

### Exposure {#sec010}

Intake of vitamins/minerals from supplements and medications was assessed in a personal interview at baseline (1994/95) and follow-up (2004/05) and also in between after 3 years from baseline investigation through a self-administered postal questionnaire in 2998 individuals (1997/98). Data from the postal questionnaire were only used for descriptive purposes. In the baseline and follow-up surveys, participants were asked to bring all product packages of preparations that were ingested during the last 7 days prior to the examination to the study center. In MONICA S3 (1994/95), the information was recorded through a questionnaire. In KORA F3 (2004/05), database supported computer software (IDOM: Instrument for databased assessment of medication) \[[@pone.0139244.ref037]\] was used. Daily amounts of regularly ingested nutrients per person were calculated for each survey from a database established by staff at the Helmholtz Zentrum München, which has been updated regularly \[[@pone.0139244.ref038]\]. Both total carotenoids and β-carotene intakes were investigated, but we restricted our main analyses to carotenoids, as the number of missing values was lower here.

Regular intake of each nutrient was investigated by dividing average intake amount per day into tertiles. Additionally, intake was analyzed binarily (regular vs no intake). For all analyses, the reference group comprised those who did not take the specific nutrient of interest. Cut-off points for tertiles were built from the means of the cut-off points from daily intake amounts at baseline and follow-up (see [S1 Table](#pone.0139244.s002){ref-type="supplementary-material"}).

### Potential confounders {#sec011}

In both surveys, data regarding sex, age, physical activity, smoking status, alcohol intake, healthy diet, and medication intake were collected during a standardized face-to-face interview by trained medical staff \[[@pone.0139244.ref036]\]. For information on years of education and family history of diabetes, i.e., diabetes of the mother or father, only the baseline survey was considered. Participants who did not know whether their mother or father suffered or died from diabetes were added to the group that answered this question with "yes". Education was defined through a combination of years of schooling and professional education and divided into a low (8--10 years) and high (11--17 years) level of education. Physical activity included frequency and duration of activity in summer and winter and was divided into four categories. Smoking status was divided into current (regular and irregular), former, and never smoking. Alcohol intake during the last week was assessed, and an average daily intake amount was calculated based on the alcohol intake during the last weekend and the last weekday prior to each examination. Sex-specific categories were created as follows: moderate intake (\> 0 to \< 20 g alcohol per day (g/d) (women) and \> 0 to \< 40 g/d (men)), high intake (≥ 20 g/d (women) and ≥ 40 g/d (men)), and no intake (0 g/d (men and women)). A food frequency questionnaire with 15 food items was used to build a healthy diet score according to the recommendations of the German Nutrition Society 1989 with higher values representing a healthier diet \[[@pone.0139244.ref039]\]. As food intake was only assessed through a short food frequency questionnaire in the total study sample which did not allow us to calculate intake levels for individual nutrients from diet, we restricted our analyses to intake of nutrients from dietary supplements. Medication that increased HbA~1c~ levels included beta-blockers, diuretics, and regular intake of systemic corticoids.

Anthropometric data (body mass index (BMI), waist--hip ratio (WHR)), information on hypertension, and cholesterol levels were collected during health examinations by trained medical staff. To calculate the BMI, participants' weight and height were measured, and categories were applied according to the WHO. The WHR was calculated as the ratio between waist and hip circumferences and categorized as low (men \< 1, women \< 0.85) and high (men ≥ 1, women ≥ 0.85). Hypertension was defined as a systolic blood pressure ≥ 140 mmHg and/or diastolic blood pressure ≥ 90 mmHg or if the participant was taking antihypertensive medication and was aware of being hypertensive. Total and high density lipoprotein (HDL) cholesterol were measured using the CHOD-PAP method (Dade Behring) with CVs \< 5% at baseline and follow-up.

Statistical analyses {#sec012}
--------------------

Age- and sex-adjusted mean levels of HbA~1c~ by categories of covariables and exposure variables were compared using analysis of covariance. To account for the intra-individual correlation, generalized estimating equation (GEE) models using the compound symmetry correlation structure were performed by the Statistical Analysis Systems (SAS) procedure GENMOD for investigation of the long-term association between vitamin/mineral intake from supplements/medications and HbA~1c~ levels. As results, the beta estimates of the interaction terms of each nutrient tertile of interest with time (coded 0/1) are presented (β~x~). These reflect the difference in change in HbA~1c~ levels between the nutrient tertile of interest and the reference group. Furthermore, beta estimates of time are displayed, which reflect the average change in HbA~1c~ levels in the reference group (β~t~). Estimates for each nutrient tertile of interest show the difference in HbA~1c~ levels at baseline compared with the reference group (β~0~).

Continuous covariates were investigated continuously if their association with the outcome was linear in cross-sectional analysis using univariable linear regression models; otherwise, they were categorized. The following variables were included in the models as potential confounders: sex, age (continuously), education (high/low), BMI (three groups), WHR (two groups), physical activity (four groups), smoking (three groups), alcohol intake (three sex-specific categories), healthy diet score (continuously), total/HDL cholesterol (continuously), actual hypertension (yes/no), diabetes of the father (yes/no), diabetes of the mother (yes/no), intake of HbA~1c~ increasing medication (yes/no).

The level of statistical significance was Bonferroni corrected and set at p \< 0.0045 (11 investigated nutrients). Statistical analyses were performed using SAS version 9.3 (SAS Institute Inc, Cary, NC, USA).

Sensitivity analyses {#sec013}
--------------------

As sensitivity analyses, individuals were excluded who 1) developed diabetes during the 10-year follow-up period (n = 142); and 2) had baseline HbA~1c~ levels \> 5.7% (n = 354) \[[@pone.0139244.ref040]\], as supplementation of nutrients in those with impaired glucose regulation might already be too late to exert beneficial effects \[[@pone.0139244.ref014]\]. Furthermore, stratified analyses according to smoking status were conducted to investigate the association between carotenoid intake and HbA~1c~ levels, because detrimental effects of β-carotene have been reported in smokers \[[@pone.0139244.ref041]\]. We also conducted longitudinal analyses only in those without any missing values in vitamin/mineral intake and HbA~1c~ values at baseline and follow-up (n = 2630).

Results {#sec014}
=======

Descriptive analyses {#sec015}
--------------------

Unadjusted mean (standard error of the mean, SEM) HbA~1c~ levels in the study population were 5.12 (0.01) at baseline (n = 4133) and 5.28 (0.01) at follow-up (n = 2774). Description of adjusted mean HbA~1c~ levels by participant characteristics is provided in [Table 1](#pone.0139244.t001){ref-type="table"}. Adjusted mean levels of HbA~1c~ according to exposure categories are presented in [Table 2](#pone.0139244.t002){ref-type="table"}. Regular intake of each investigated nutrient increased constantly from baseline over the 3-year to the 10-year follow-up (see [S1 Fig](#pone.0139244.s001){ref-type="supplementary-material"}). The proportion of individuals with constant regular intake of nutrients, i.e., regular intakes at baseline and follow-up, in relation to those with regular intake of that nutrient at baseline ranged between 10.0% (iron) and 31.0% (selenium).

10.1371/journal.pone.0139244.t001

###### Characteristics of the study population with adjusted mean levels of HbA~1c~ at baseline (1994/95) and follow-up (2004/05).
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                                                          Baseline (1994/95)   Follow-up (2004/05)                                                
  ----------------------------------- ------------------- -------------------- --------------------- ------------- -- ------ ------ ------------- --
  **Age (years at baseline)**                                                                        \<0.001                        \<0.001       
                                      25--34              893                  833                   4.97 (0.01)      592    589    5.13 (0.01)   
                                      35--44              949                  892                   5.04 (0.01)      674    671    5.22 (0.01)   
                                      45--54              904                  867                   5.13 (0.01)      649    649    5.31 (0.01)   
                                      55--64              910                  840                   5.20 (0.01)      558    557    5.37 (0.01)   
                                      65--74              791                  701                   5.31 (0.02)      301    300    5.49 (0.02)   
  **Sex**                                                                                            \<0.001                        0.290         
                                      Male                2187                 2093                  5.04 (0.01)      1342   1338   5.28 (0.01)   
                                      Female              2260                 2040                  5.21 (0.01)      1432   1428   5.29 (0.01)   
  **Education**                                                                                      0.009                          \<0.001       
                                      Low                 2526                 2339                  5.14 (0.01)      1445   1442   5.32 (0.01)   
                                      High                1920                 1794                  5.10 (0.01)      1329   1324   5.25 (0.01)   
  **BMI (kg/m** ^**2**^ **)**                                                                        \<0.001                        \<0.001       
                                      \< 25               1611                 1498                  5.10 (0.01)      863    861    5.22 (0.01)   
                                      ≥ 25 to \< 30       1922                 1817                  5.12 (0.01)      1210   1207   5.28 (0.01)   
                                      ≥ 30                866                  793                   5.18 (0.02)      680    679    5.37 (0.01)   
  **Waist--hip ratio**                                                                               0.104                          \<0.001       
                                      High                646                  575                   5.15 (0.02)      728    728    5.39 (0.01)   
                                      Low                 3762                 3538                  5.12 (0.01)      2033   2027   5.25 (0.01)   
  **Physical activity**                                                                              0.006                          \<0.001       
                                      Very active         883                  835                   5.10 (0.01)      635    635    5.24 (0.01)   
                                      Moderately active   1074                 1018                  5.11 (0.01)      827    823    5.27 (0.01)   
                                      Less active         663                  637                   5.10 (0.02)      413    413    5.32 (0.02)   
                                      Inactive            1825                 1642                  5.15 (0.01)      891    889    5.31 (0.01)   
  **Smoking**                                                                                        0.571                          0.087         
                                      Current             1140                 1067                  5.14 (0.01)      527    526    5.31 (0.02)   
                                      Former              1348                 1263                  5.12 (0.01)      1015   1012   5.28 (0.01)   
                                      Never               1959                 1803                  5.12 (0.01)      1224   1222   5.27 (0.01)   
  **Alcohol consumption**                                                                            \<0.001                        \<0.001       
                                      None                1440                 1305                  5.16 (0.01)      768    766    5.34 (0.01)   
                                      Moderate            2050                 1929                  5.13 (0.01)      1439   1436   5.28 (0.01)   
                                      High                956                  898                   5.07 (0.01)      557    556    5.22 (0.01)   
  **Healthy diet**                                                                                   0.786                          0.356         
                                      Unfavorable         1348                 1258                  5.13 (0.01)      682    680    5.27 (0.01)   
                                      Normal              904                  848                   5.12 (0.01)      424    423    5.26 (0.02)   
                                      Favorable           2190                 2023                  5.12 (0.01)      1358   1356   5.25 (0.01)   
  **Hypertension**                                                                                   0.679                          \<0.001       
                                      Yes                 1733                 1598                  5.12 (0.01)      1306   1303   5.31 (0.01)   
                                      No                  2714                 2535                  5.13 (0.01)      1452   1449   5.26 (0.01)   
  **Cholesterol/HDL ratio**                                                                          \<0.001                        \<0.001       
                                      \< 3.5              1216                 1158                  5.08 (0.01)      1169   1169   5.24 (0.01)   
                                      ≥ 3.5 to \< 5.0     1631                 1578                  5.12 (0.01)      1061   1060   5.29 (0.01)   
                                      ≥ 5.0               1456                 1394                  5.17 (0.01)      537    537    5.36 (0.01)   
  **Diabetes mellitus (father)**                                                                     0.001                          0.010         
                                      Yes                 1136                 1054                  5.16 (0.01)      696    694    5.31 (0.01)   
                                      No                  3309                 3077                  5.11 (0.01)      2077   2071   5.27 (0.01)   
  **Diabetes mellitus (mother)**                                                                     \<0.001                        0.007         
                                      Yes                 937                  874                   5.17 (0.01)      544    542    5.32 (0.01)   
                                      No                  3508                 3257                  5.11 (0.01)      2229   2223   5.27 (0.01)   
  **HbA** ~**1c**~ **↑ medication**                                                                  0.736                          \<0.001       
                                      Yes                 555                  499                   5.13 (0.02)      677    675    5.34 (0.01)   
                                      No                  3888                 3630                  5.12 (0.01)      2090   2086   5.26 (0.01)   

BMI = body mass index, HbA~1c~ = hemoglobin A~1c~, HDL = high density lipoprotein, SEM = standard error of the mean

\*age- and sex-adjusted mean HbA~1c~, for adjustment age was treated continuously, age was only sex adjusted, sex was only age adjusted

\*\*p for adjusted mean difference (analysis of covariance); numbers of people in categories in column "n Total" do not sum up to the number in the total study population because of missing values.

10.1371/journal.pone.0139244.t002

###### Adjusted mean levels of HbA~1c~ by categories of exposure variables at baseline (1994/95) and follow-up (2004/05).
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                                      Baseline (1994/95)   Follow-up (2004/05)                                                     
  ----------------------- ----------- -------------------- --------------------- ------------- ------- ------ ------ ------------- -------
  **Vitamin E**                                                                                0.256                               0.934
                          No intake   4037                 3744                  5.13 (0.01)           2321   2316   5.28 (0.01)   
                          Tertile 1   104                  97                    5.18 (0.04)           126    126    5.28 (0.03)   
                          Tertile 2   84                   81                    5.11 (0.05)           132    132    5.26 (0.03)   
                          Tertile 3   88                   80                    5.04 (0.05)           148    147    5.27 (0.03)   
  **Vitamin C**                                                                                0.456                               0.410
                          No intake   3882                 3597                  5.13 (0.01)           2255   2249   5.29 (0.01)   
                          Tertile 1   119                  112                   5.13 (0.04)           163    163    5.27 (0.03)   
                          Tertile 2   80                   75                    5.14 (0.05)           107    107    5.23 (0.03)   
                          Tertile 3   114                  108                   5.06 (0.04)           136    136    5.29 (0.03)   
  **Vitamin D**                                                                                0.764                               0.049
                          No intake   4328                 4026                  5.13 (0.01)           2500   2494   5.29 (0.01)   
                          Tertile 1   30                   26                    5.06 (0.08)           45     45     5.17 (0.05)   
                          Tertile 2   42                   38                    5.09 (0.07)           148    148    5.30 (0.03)   
                          Tertile 3   15                   14                    5.05 (0.11)           50     50     5.24 (0.05)   
  **Vitamin B** ~**1**~                                                                        0.873                               0.491
                          No intake   4101                 3810                  5.13 (0.01)           2453   2447   5.28 (0.01)   
                          Tertile 1   83                   79                    5.16 (0.05)           122    122    5.28 (0.03)   
                          Tertile 2   53                   49                    5.09 (0.06)           62     62     5.23 (0.04)   
                          Tertile 3   88                   78                    5.09 (0.05)           90     90     5.31 (0.04)   
  **Folic acid**                                                                               0.291                               0.745
                          No intake   4204                 3901                  5.13 (0.01)           2437   2431   5.28 (0.01)   
                          Tertile 1   53                   50                    5.10 (0.06)           62     62     5.32 (0.04)   
                          Tertile 2   55                   55                    5.13 (0.06)           126    126    5.27 (0.03)   
                          Tertile 3   37                   33                    4.97 (0.07)           106    106    5.29 (0.03)   
  **Carotenoids**                                                                              0.199                               0.420
                          No intake   4375                 4066                  5.12 (0.01)           2608   2602   5.28 (0.01)   
                          Tertile 1   18                   16                    5.02 (0.11)           40     40     5.31 (0.05)   
                          Tertile 2   13                   13                    5.11 (0.12)           58     58     5.28 (0.04)   
                          Tertile 3   18                   17                    5.33 (0.10)           46     46     5.20 (0.05)   
  **Calcium**                                                                                  0.778                               0.678
                          No intake   4073                 3789                  5.12 (0.01)           2398   2392   5.28 (0.01)   
                          Tertile 1   106                  98                    5.10 (0.04)           69     69     5.25 (0.04)   
                          Tertile 2   93                   87                    5.14 (0.05)           121    121    5.27 (0.03)   
                          Tertile 3   63                   56                    5.12 (0.06)           131    131    5.28 (0.03)   
  **Magnesium**                                                                                0.652                               0.118
                          No intake   3963                 3681                  5.13 (0.01)           2253   2247   5.29 (0.01)   
                          Tertile 1   133                  124                   5.14 (0.04)           122    122    5.26 (0.03)   
                          Tertile 2   132                  121                   5.07 (0.04)           155    155    5.24 (0.03)   
                          Tertile 3   75                   72                    5.12 (0.05)           144    144    5.32 (0.03)   
  **Zinc**                                                                                     0.329                               0.794
                          No intake   4365                 4060                  5.12 (0.01)           2480   2475   5.28 (0.01)   
                          Tertile 1   46                   40                    5.09 (0.07)           41     41     5.27 (0.05)   
                          Tertile 2   1                    1                     4.49 (0.42)           10     10     5.26 (0.11)   
                          Tertile 3   8                    8                     5.30 (0.15)           202    201    5.27 (0.02)   
  **Iron**                                                                                     0.886                               0.345
                          No intake   4303                 4005                  5.13 (0.01)           2605   2599   5.28 (0.01)   
                          Tertile 1   32                   29                    5.09 (0.08)           103    103    5.27 (0.03)   
                          Tertile 2   19                   17                    5.07 (0.10)           16     16     5.17 (0.08)   
                          Tertile 3   59                   51                    5.09 (0.06)           23     23     5.24 (0.07)   
  **Selenium**                                                                                 0.845                               0.201
                          No intake   4404                 4093                  5.13 (0.01)           2569   2563   5.29 (0.01)   
                          Tertile 1   5                    5                     5.01 (0.19)           112    112    5.25 (0.03)   
                          Tertile 2   13                   12                    5.10 (0.12)           27     27     5.27 (0.07)   
                          Tertile 3   11                   11                    5.09 (0.13)           37     37     5.29 (0.06)   

HbA~1c~ = hemoglobin A~1c~, SEM = standard error of the mean

\*age- and sex-adjusted mean HbA~1c~, for adjustment age was treated continuously

\*\*p for adjusted mean difference (analysis of covariance); numbers of people in categories in column "n Total" do not sum up to the number in the total study population because of missing values and because subjects with intakes as needed are not listed.

Main analysis {#sec016}
-------------

After 10 years, the HbA~1c~ levels of participants who comprised the reference group (no intake) for each investigated nutrient increased by about 0.1% from baseline (see β~t~ in [Table 3](#pone.0139244.t003){ref-type="table"}). Participants with carotenoid intakes in the upper tertile had a 0.26% lower increase in HbA~1c~ values after 10 years than those with no intake of carotenoids (see β~x~ in **[Table 3](#pone.0139244.t003){ref-type="table"}**). It is noteworthy that participants with carotenoid intakes in the upper tertile had 0.22% higher HbA~1c~ levels at baseline compared with the reference group (see β~0~ in [Table 3](#pone.0139244.t003){ref-type="table"}), even though this difference was marginally not statistically significant after Bonferroni correction (p = 0.005). The intake of none of the other investigated nutrient tertiles was significantly associated with concentrations of HbA~1c~ after correction for multiple testing (see **[Table 3](#pone.0139244.t003){ref-type="table"}**). Treating the exposure to regular intake of each nutrient as binary variables (regular intake vs no intake) yielded analogous findings, whereas the association of regular carotenoid intake with HbA~1c~ levels was not statistically significant (data not shown).

10.1371/journal.pone.0139244.t003

###### Longitudinal association between regular supplement intake and HbA~1c~ (1994/95--2004/05); results from generalized estimating equations (GEE).
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                                                                                                          Tertile 1               Tertile 2               Tertile 3                                                                
  ----------------------- ----------------------------------------------------- ------------------------- ----------------------- ----------------------- ----------------------- ----------------------- ------------------------ ----------------------------
  **Vitamin E**                                                                                                                                                                                                                    
                          Sex- and age-adjusted                                 **0.09 (0.07 to 0.11)**   0.07 (-0.02 to 0.15)    -0.08 (-0.18 to 0.02)   -0.00 (-0.09 to 0.09)   -0.02 (-0.12 to 0.08)   -0.09 (-0.18 to -0.01)   0.07 (-0.02 to 0.17)
                          Fully adjusted[\*](#t003fn002){ref-type="table-fn"}   **0.10 (0.08 to 0.12)**   0.08 (-0.00 to 0.17)    -0.10 (-0.20 to 0.01)   0.01 (-0.08 to 0.10)    -0.01 (-0.11 to 0.09)   -0.08 (-0.16 to 0.01)    0.08 (-0.02 to 0.17)
  **Vitamin C**                                                                                                                                                                                                                    
                          Sex- and age-adjusted                                 **0.10 (0.08 to 0.11)**   0.02 (-0.05 to 0.10)    -0.05 (-0.13 to 0.04)   0.01 (-0.09 to 0.11)    -0.09 (-0.20 to 0.03)   -0.06 (-0.13 to 0.01)    0.06 (-0.03 to 0.14)
                          Fully adjusted[\*](#t003fn002){ref-type="table-fn"}   **0.11 (0.09 to 0.13)**   0.04 (-0.04 to 0.11)    -0.05 (-0.13 to 0.04)   0.03 (-0.08 to 0.13)    -0.09 (-0.21 to 0.02)   -0.05 (-0.12 to 0.03)    0.05 (-0.04 to 0.14)
  **Vitamin D**                                                                                                                                                                                                                    
                          Sex- and age-adjusted                                 **0.10 (0.08 to 0.11)**   -0.08 (-0.23 to 0.06)   -0.03 (-0.19 to 0.13)   -0.02 (-0.15 to 0.10)   -0.00 (-0.14 to 0.14)   -0.04 (-0.20 to 0.12)    -0.04 (-0.21 to 0.13)
                          Fully adjusted[\*](#t003fn002){ref-type="table-fn"}   **0.11 (0.09 to 0.13)**   -0.05 (-0.20 to 0.10)   -0.04 (-0.20 to 0.12)   -0.01 (-0.14 to 0.12)   -0.03 (-0.17 to 0.10)   -0.06 (-0.23 to 0.12)    -0.00 (-0.20 to 0.19)
  **Vitamin B** ~**1**~                                                                                                                                                                                                            
                          Sex- and age-adjusted                                 **0.09 (0.07 to 0.11)**   0.05 (-0.04 to 0.14)    -0.08 (-0.19 to 0.02)   -0.03 (-0.14 to 0.09)   -0.02 (-0.15 to 0.11)   -0.04 (-0.13 to 0.06)    0.05 (-0.06 to 0.17)
                          Fully adjusted[\*](#t003fn002){ref-type="table-fn"}   **0.10 (0.09 to 0.12)**   0.06 (-0.03 to 0.15)    -0.07 (-0.18 to 0.04)   -0.01 (-0.12 to 0.10)   -0.00 (-0.13 to 0.13)   -0.02 (-0.12 to 0.07)    0.01 (-0.10 to 0.12)
  **Folic acid**                                                                                                                                                                                                                   
                          Sex- and age-adjusted                                 **0.09 (0.07 to 0.11)**   0.00 (-0.10 to 0.11)    0.02 (-0.11 to 0.16)    0.02 (-0.09 to 0.13)    -0.06 (-0.18 to 0.07)   -0.16 (-0.30 to -0.02)   0.13 (-0.01 to 0.28)
                          Fully adjusted[\*](#t003fn002){ref-type="table-fn"}   **0.10 (0.08 to 0.12)**   0.01 (-0.09 to 0.12)    0.02 (-0.11 to 0.15)    0.02 (-0.09 to 0.14)    -0.04 (-0.17 to 0.09)   -0.13 (-0.26 to -0.01)   0.12 (-0.02 to 0.25)
  **Carotenoids**                                                                                                                                                                                                                  
                          Sex- and age-adjusted                                 **0.09 (0.07 to 0.11)**   -0.08 (-0.30 to 0.13)   0.08 (-0.16 to 0.32)    -0.00 (-0.27 to 0.26)   -0.00 (-0.28 to 0.27)   0.19 (0.04 to 0.35)      **-0.27 (-0.45 to -0.10)**
                          Fully adjusted[\*](#t003fn002){ref-type="table-fn"}   **0.10 (0.09 to 0.12)**   -0.08 (-0.30 to 0.13)   0.07 (-0.17 to 0.31)    0.02 (-0.25 to 0.30)    -0.03 (-0.31 to 0.25)   0.22 (0.07 to 0.38)      **-0.26 (-0.43 to -0.08)**
  **Calcium**                                                                                                                                                                                                                      
                          Sex- and age-adjusted                                 **0.10 (0.08 to 0.12)**   -0.02 (-0.10 to 0.07)   -0.04 (-0.14 to 0.07)   0.04 (-0.04 to 0.12)    -0.07 (-0.17 to 0.02)   -0.00 (-0.11 to 0.11)    -0.04 (-0.16 to 0.08)
                          Fully adjusted[\*](#t003fn002){ref-type="table-fn"}   **0.11 (0.09 to 0.13)**   0.00 (-0.08 to 0.09)    -0.08 (-0.18 to 0.02)   0.03 (-0.05 to 0.11)    -0.05 (-0.14 to 0.05)   -0.01 (-0.12 to 0.10)    -0.04 (-0.16 to 0.08)
  **Magnesium**                                                                                                                                                                                                                    
                          Sex- and age-adjusted                                 **0.09 (0.08 to 0.11)**   0.02 (-0.06 to 0.09)    -0.04 (-0.13 to 0.04)   -0.06 (-0.13 to 0.01)   0.00 (-0.08 to 0.08)    0.00 (-0.10 to 0.11)     0.00 (-0.12 to 0.12)
                          Fully adjusted[\*](#t003fn002){ref-type="table-fn"}   **0.11 (0.09 to 0.13)**   0.03 (-0.05 to 0.10)    -0.06 (-0.15 to 0.03)   -0.05 (-0.12 to 0.02)   0.00 (-0.08 to 0.08)    -0.00 (-0.10 to 0.10)    0.02 (-0.10 to 0.14)
  **Iron**                                                                                                                                                                                                                         
                          Sex- and age-adjusted                                 **0.09 (0.08 to 0.11)**   -0.06 (-0.19 to 0.06)   0.04 (-0.09 to 0.18)    -0.06 (-0.24 to 0.13)   -0.08 (-0.27 to 0.11)   -0.02 (-0.13 to 0.09)    -0.06 (-0.23 to 0.11)
                          Fully adjusted[\*](#t003fn002){ref-type="table-fn"}   **0.11 (0.09 to 0.12)**   -0.03 (-0.15 to 0.09)   0.00 (-0.13 to 0.14)    -0.05 (-0.24 to 0.14)   -0.06 (-0.26 to 0.14)   -0.00 (-0.11 to 0.11)    -0.10 (-0.26 to 0.06)
  **Selenium**                                                                                                                                                                                                                     
                          Sex- and age-adjusted                                 **0.09 (0.07 to 0.11)**   -0.05 (-0.25 to 0.15)   0.02 (-0.19 to 0.23)    -0.00 (-0.29 to 0.29)   -0.02 (-0.33 to 0.30)   -0.07 (-0.34 to 0.19)    0.09 (-0.18 to 0.37)
                          Fully adjusted[\*](#t003fn002){ref-type="table-fn"}   **0.10 (0.09 to 0.12)**   -0.01 (-0.17 to 0.16)   -0.03 (-0.20 to 0.15)   0.01 (-0.29 to 0.31)    -0.06 (-0.36 to 0.25)   -0.05 (-0.33 to 0.24)    0.09 (-0.21 to 0.39)

CI = confidence interval, HbA~1c~ = hemoglobin A~1c~; ß~t~ = average change in HbA~1c~ between baseline (1994/95) and follow-up (2004/05) in the reference group "no intake", ß~0~ = difference in HbA~1c~ at baseline compared with the reference group "no intake", ß~x~ = difference in change in HbA~1c~ compared with the reference group "no intake"; significant associations after Bonferroni correction are presented in bold font

\*adjusted for: sex, age, BMI, waist--hip ratio, physical activity, smoking, alcohol intake, healthy diet, total/HDL cholesterol, hypertension, diabetes of the father, diabetes of the mother, intake of HbA~1c~ increasing medication; as building tertiles with nearly similar numbers of people was not possible for zinc intake, results for zinc intake are not presented.

Sensitivity analyses {#sec017}
--------------------

Excluding 142 participants who developed diabetes during the 10-year follow-up resulted in similar findings to the main analysis, apart from the fact that the inverse association between the upper carotenoid tertile and change in HbA~1c~ levels was not statistically significant (data not shown). Like in the main analysis, after exclusion of 354 participants with baseline HbA~1c~ levels \> 5.7%, the increase in HbA~1c~ levels in individuals with intakes of carotenoids in the upper tertile was significantly lower (β~x~ = --0.29% (95% CI: --0.45 to --0.12)) compared with individuals with no intake of carotenoids (p = 0.0006). Unlike in the main analysis, the difference in baseline HbA~1c~ levels of 0.25% (95% CI: 0.11 to 0.39) between those with the highest intakes of carotenoids compared with those with no intake was statistically significant.

In the smoking status-stratified analyses of carotenoid intake and HbA~1c~ levels, the results for current and former smokers were pooled together, as they did not differ substantially (data not shown). A longitudinal inverse association of the upper carotenoid tertile with HbA~1c~ level was significant in participants who never smoked (β~x~ = --0.43% (95% CI: --0.63 to --0.24), p \< 0.0001), but not in current or former smokers (β~x~ = --0.11% (95% CI: --0.39 to 0.17), p = 0.451) (see [Fig 1](#pone.0139244.g001){ref-type="fig"}). Never smokers with carotenoid intakes in the upper tertile had higher baseline HbA~1c~ values than never smokers with no intake of carotenoids (β~0~ = 0.33 (95% CI: 0.18 to 0.48), p \< 0.0001)~.~

![Longitudinal association between regular carotenoid intake amount from supplements and medications in tertiles and levels of HbA~1c~ over 10 years (1994/95 to 2004/05).\
n~Total\ population~ = 4447, n~never\ smokers~ = 1959, n~(former)\ smokers~ = 2498; 10 people who stated they were never smokers at baseline but smokers at follow-up were partly used for both strata for the appropriate time point; HbA~1c~ beta estimates (β~x~) result from fully adjusted generalized estimating equation models and refer to interaction terms with time (represents the difference in change in HbA~1c~ levels compared with those with no intake of carotenoids, see β~x~ in [Table 3](#pone.0139244.t003){ref-type="table"} for total population); cut-off point for tertiles 1 and 2: 1.9 mg/d; for tertiles 2 and 3: 6.8 mg/d.](pone.0139244.g001){#pone.0139244.g001}

The results when restricting the study population to participants without any missing values in exposure and outcome at baseline and follow-up were similar to the main analysis (data not shown).

Discussion {#sec018}
==========

We investigated the longitudinal association of regular intake of vitamin E, vitamin C, vitamin D, vitamin B~1~, folic acid, carotenoids, calcium, magnesium, zinc, iron, and selenium from supplements and medications with levels of HbA~1c~ in the general non-diabetic population. The results indicate that there is an inverse association of regular carotenoid intakes above 6.8 mg/d with concentrations of HbA~1c~ after 10 years and no significant association of intake of the other investigated vitamins and minerals with HbA~1c~ levels. The observed reduction of 0.3 absolute percentage points in HbA~1c~ levels in the upper carotenoid tertile can be regarded as clinically relevant, as a reduction of 0.1% in the general non-diabetic population could lead to a reduction in mortality of up to 6% over a period of 6 years \[[@pone.0139244.ref009]\].

Comparison with the literature {#sec019}
------------------------------

Previous intervention studies examining the effect of use of vitamins/minerals on HbA~1c~ levels have mostly been conducted in diabetic or prediabetic subjects and found inconsistent results. Significant inverse associations with HbA~1c~ levels were reported for vitamins E, C, D, B~1~, folic acid, calcium, magnesium, zinc, iron, and selenium supplemented either alone or in combination \[[@pone.0139244.ref012],[@pone.0139244.ref019],[@pone.0139244.ref021],[@pone.0139244.ref022],[@pone.0139244.ref024],[@pone.0139244.ref026],[@pone.0139244.ref042]\]. Other intervention studies found no significant associations for vitamins E, C, D, B~1~, folic acid, carotenoids, calcium, magnesium, and zinc \[[@pone.0139244.ref010],[@pone.0139244.ref011],[@pone.0139244.ref013]--[@pone.0139244.ref015],[@pone.0139244.ref017],[@pone.0139244.ref018],[@pone.0139244.ref020],[@pone.0139244.ref023],[@pone.0139244.ref025]\]. In contrast, significant positive associations were also observed for vitamin D, folic acid, and selenium \[[@pone.0139244.ref016],[@pone.0139244.ref027],[@pone.0139244.ref043]\].

Inadequacy of baseline nutrient status might influence the efficacy of supplementation, as single studies that reported a protective role for supplemented nutrients (iron, vitamin D with calcium) were conducted in those with inadequate baseline status \[[@pone.0139244.ref021],[@pone.0139244.ref026]\]. Furthermore, a recently published meta-analysis on vitamin E supplementation found that HbA~1c~ lowering effects might rather be present in people with low baseline vitamin E status \[[@pone.0139244.ref010]\]. The same study reported that vitamin E dosages above 400 mg/d might be necessary to result in decreased HbA~1c~ levels. In the present study, two thirds of all subjects who regularly supplemented vitamin E ingested daily amounts of less than 66 mg.

One explanation for the null findings in some of the above mentioned studies is that all were conducted in (pre-)diabetic or high risk populations. The state of dysglycemia might already be too advanced to facilitate beneficial effects of vitamin supplementation \[[@pone.0139244.ref011],[@pone.0139244.ref014]\]. Therefore, further intervention studies are warranted in non-diabetic and also in non-prediabetic individuals to investigate the relationship between vitamin/mineral intake and HbA~1c~ levels.

Carotenoids {#sec020}
-----------

In the present study, regular intake of \> 6.8 mg of carotenoids per day from supplements and medications, which corresponds to the upper tertile, was associated with an about 0.3% lower increase in HbA~1c~ concentrations after 10 years. Similar dose--effect results were presented by Akbaraly et al. from the Epidemiology of Vascular Ageing (EVA) study; however, they investigated plasma carotenoid levels as exposure with regard to other diabetes related outcomes in elderly volunteers \[[@pone.0139244.ref044]\]. They found that the risk of dysglycemia was significantly lower in the highest plasma carotenoid quartile after 9 years of follow-up.

Prospective studies on the association of carotenoids (intake or plasma/serum levels) with HbA~1c~ levels as an outcome have not, to our knowledge, been published so far. Cross-sectional studies in healthy subjects reported an inverse association \[[@pone.0139244.ref031],[@pone.0139244.ref032]\], or no association \[[@pone.0139244.ref030]\]. A randomized controlled trial (RCT) detected no significant effect with regard to lowering of HbA~1c~ levels \[[@pone.0139244.ref013]\]. However, the trial was conducted in people with type 2 diabetes \[[@pone.0139244.ref013]\]. To our knowledge, there is currently no RCT that investigated the effect of carotenoids on HbA~1c~ levels in healthy individuals. Also, the safety of carotenoid supplementation in higher dosages has to be confirmed in future studies, as detrimental effects have been found for β-carotene not only in smokers with dosages above 20 mg/d \[[@pone.0139244.ref041]\], but also in a pooled analysis of diverse populations with dosages ranging from 15 to 50 mg/d \[[@pone.0139244.ref045]\]. The main carotenoid ingested in the present study population was β-carotene. Some 98.0% and 68.1%, respectively, of all those who regularly ingested carotenoids at baseline and follow-up took β-carotene. Mean (SD) intake amount in the upper tertile of carotenoids was 15.4 (9.2) mg with a maximum value of 50 mg.

### Mechanism {#sec021}

A potential mechanism for a HbA~1c~ lowering effect of carotenoids might be their antioxidant activity \[[@pone.0139244.ref046]\], which is closely related to protein glycosylation \[[@pone.0139244.ref047]\]. However, controlling for several antioxidative markers in the EVA study mentioned above did not change the result of a lower risk of dysglycemia with higher plasma carotenoids \[[@pone.0139244.ref044]\]. Furthermore, intake of the other investigated antioxidants (vitamin E, vitamin C, zinc, and selenium) from supplements or medications was not significantly associated with lower HbA~1c~ values in the present investigation. Recently, Bumke-Vogt et al. \[[@pone.0139244.ref048]\] reported that, apart from carotenoids, another subgroup of phytochemicals resulted in down-regulation of gluconeogenic gene expression in human hepatoma cells, an effect not attributed to their antioxidant activity \[[@pone.0139244.ref048]\]. This suggests that phytochemicals might exert other effects than hitherto known.

### Smoking status {#sec022}

Stratified analyses according to smoking status showed that an inverse association of carotenoids and HbA~1c~ levels is only present in those who have never smoked. These results support previous findings by Hozawa et al., who investigated serum carotenoid levels as exposure and diabetes incidence and insulin concentrations as outcomes in the Coronary Artery Risk Development in Young Adults (CARDIA) study \[[@pone.0139244.ref049]\]. The authors concluded that higher serum carotenoid levels are significantly associated with a lower risk of diabetes and insulin resistance after 15 years only in non-smokers, but not in smokers.

Strengths and limitations {#sec023}
-------------------------

A limitation of the present study is that measurements of HbA~1c~ and covariables were only available for two time points. Intake of supplements was assessed at three time points. Furthermore, there were no detailed data available on nutrient intakes from diet, and we only adjusted for a diet score that represents a healthy or an unhealthy eating pattern. However, we believe that dietary habits remained rather constant during the study period, as the categorized healthy diet score remained the same in 56% of the participants with available information at baseline and follow-up. An important limitation is the small (and also unequal) number of participants in some nutrient tertiles, which might have underpowered the present analyses. Furthermore, variation in baseline HbA~1c~ levels was high in specific tertile groups, and the results might be driven by outliers. Moreover, plasma levels were not measured, although these do not always represent intake of nutrients, especially if a high turnover is present, such as with antioxidant levels in smokers \[[@pone.0139244.ref050]\]. Inadequacy of baseline status of nutrients was not considered in the present analysis, but might influence the efficacy of supplementation \[[@pone.0139244.ref010],[@pone.0139244.ref021],[@pone.0139244.ref026]\]. With respect to vitamin E, ingested dosages might have been too low. Another important point to consider is that participants with the highest intakes of carotenoids at baseline had relatively high baseline levels of HbA~1c~. Therefore, regression to the mean might be present and might lead to biased results with regard to the inverse longitudinal association. We also cannot exclude the possibility that the results are due to residual confounding, as this is an observational study, even if the beta estimates did not differ greatly between the raw and fully adjusted models.

The strengths of the present study include the long follow-up duration of 10 years, the availability of important covariables not only at baseline but also at follow-up, and the thorough assessment of vitamin/mineral intake from supplements and medications. The availability of average daily intake amounts of nutrients allowed the conduct of dose--effect analyses, which are crucial in the investigation of physiological nutrient effects. Furthermore, this represents a population-based study of healthy non-diabetic individuals. Therefore, the results can be transferred to the general population. Finally, HbA~1c~ exhibits a lower biological variability compared with other glycemic outcomes \[[@pone.0139244.ref051]\] and is strongly associated with cardiovascular disease risk in non-diabetic people \[[@pone.0139244.ref008]\].

Future perspectives {#sec024}
-------------------

Larger prospective studies on vitamin/mineral intake or blood levels and HbA~1c~ concentrations are needed to confirm the results of the present analyses. If the results regarding a significant inverse association of higher carotenoid intakes with HbA~1c~ levels are replicated, RCTs can be conducted, especially in non-smokers and those without diabetes, to investigate the causal effect of carotenoid dosages \> 6.8 mg/d in lowering HbA~1c~ concentrations. If these studies confirm the present findings, supplementation of carotenoids might be a useful strategy in preventing the development of type 2 diabetes as well as cardiovascular complications and mortality in the general or non-smoking population.

Supporting Information {#sec025}
======================

###### Regular intake of dietary supplements over 10 years.

Data are derived from the MONICA (Monitoring of Trends and Determinants in Cardiovascular Diseases) S3 survey in 1994/95 (n = 4447), from a postal questionnaire in 1997/98 (n = 2998), and from the KORA (Cooperative Health Research in the Region of Augsburg) F3 survey in 2004/05 (n = 2774); all surveys longitudinally investigated the same individuals.

(TIF)

###### 

Click here for additional data file.

###### Cut-off points of daily intake amounts for building tertiles in baseline and follow-up surveys and their mean values.

For building of tertiles, cut-off values were included in the lower category.

(DOC)

###### 

Click here for additional data file.
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